TrialAnnals of hematology2020

Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.

Olivier Ballo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.